Delivery Order SPE2DB20D2001-SPE2DB24FM36R
- Not listed
- This federal contract award, valued at $1,704.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobrex 0.3% eye ointment, a pharmaceutical product, with a performance period ending on May 6, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,349.08 firm fixed-price contract is for the supply of Tobrex 0.3% eye ointment 3.5g. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC serves as a...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of TOBREX 0.3% eye ointment. The contract, valued at $1,608.36, was awarded by the Defense Logistics Agency (DLA) on June 9, 2025, with a completion date of June 10, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, with ID SPE2DX15D2223|SPE2DX25F4JSZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,082.87 firm fixed-price delivery order is for the supply of Tobrex 0.3% eye ointment, 3.5g. This award is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,148.34, is for the supply of Tobrex 0.3% eye ointment 3.5 gm. The order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.15 Firm Fixed Price delivery order is for TOBREX 0.3% eye ointment, with a completion date of December 11, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award, with ID SPE2DB22D2218|SPE2DB25FR1SX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobrex 0.3% eye ointment, 3.5 grams, at a ceiling value of $9,652.28. This is a Firm Fixed Price Delivery Order contract with a completion date of December 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,490.92, is for the provision of Tobrex 0.3% ophthalmic ointment. The contract is a firm-fixed-price delivery order with a completion date of May 26, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,558.97 award is for the supply of TOBREX 0.3% eye ointment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of TOBREX 0.3% Eye Ointment 3.5GM to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,042.26, has a completion date of September 16, 2024. This award is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office Division, has been awarded this contract to supply the...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM36RDelivery Order
This federal contract award, valued at $2,565.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobrex 0.3% eye ointment, a medical product used for various eye conditions. The contract has a firm fixed price and an ultimate completion date of December 22, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular contract award was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 12/21/23 |